Duration of PARP Inhibitor Maintenance Therapy in Patients With Ovarian Cancer With Germline or Somatic BRCA Mutations.
| Autor: | Billings, Joanna1,2, Kohler, Lindsay2,3, Wallace, Jordan2,4, Buckingham, Lindsey5, Cipriani, Amber6,7, Jones, Alexis8,9 |
|---|---|
| Zdroj: | Journal of Hematology Oncology Pharmacy. Feb2024, Vol. 14 Issue 1, p11-17. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|